XML 57 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
Marketable Securities
9 Months Ended
Sep. 30, 2015
Cash and Cash Equivalents [Abstract]  
Marketable Securities
Marketable Securities
A summary of the Company’s cash, cash equivalents and marketable securities is shown below:
 
Amortized Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
 
(in thousands)
As of September 30, 2015
 
 
 
 
 
 
 
Cash and cash equivalents:
 
 
 
 
 
 
 
Cash and money market funds
$
707,141

 
$

 
$

 
$
707,141

Commercial paper
$
25,109

 
$

 
$

 
$
25,109

Corporate debt securities
$
24,000

 
$

 
$

 
$
24,000

Total cash and cash equivalents
$
756,250

 
$

 
$

 
$
756,250

Marketable securities:
 
 
 
 
 
 
 
Commercial paper (due within 1 year)
$
140,131

 
$
114

 
$

 
$
140,245

Corporate debt securities (due within 1 year)
109,386

 
28

 
(79
)
 
109,335

Total marketable securities
$
249,517

 
$
142

 
$
(79
)
 
$
249,580

Total cash, cash equivalents and marketable securities
$
1,005,767

 
$
142

 
$
(79
)
 
$
1,005,830

 
 
 
 
 
 
 
 
As of December 31, 2014
 
 
 
 
 
 
 
Cash and cash equivalents:
 
 
 
 
 
 
 
Cash and money market funds
$
625,259

 
$

 
$

 
$
625,259

Total cash and cash equivalents
$
625,259

 
$

 
$

 
$
625,259

Marketable securities:
 
 
 
 
 
 
 
Government-sponsored enterprise securities (due within 1 year)
$
463,788

 
$
14

 
$
(52
)
 
$
463,750

Commercial paper (due within 1 year)
51,674

 
72

 

 
51,746

Corporate debt securities (due within 1 year)
196,065

 
2

 
(66
)
 
196,001

Corporate debt securities (due after 1 year through 5 years)
50,443

 

 
(93
)
 
50,350

Total marketable securities
$
761,970

 
$
88

 
$
(211
)
 
$
761,847

Total cash, cash equivalents and marketable securities
$
1,387,229

 
$
88

 
$
(211
)
 
$
1,387,106


The Company has a limited number of marketable securities in insignificant loss positions as of September 30, 2015, which the Company does not intend to sell and has concluded it will not be required to sell before recovery of the amortized costs for the investment at maturity. There were no charges recorded for other-than-temporary declines in fair value of marketable securities nor gross realized gains or losses recognized in the three and nine months ended September 30, 2015 and 2014.